On-Demand Workshop presented by Andreas Castan, Strategic Technologies Director at Cytiva, Cauroline Hausner, Business Development Manager, Aseptic Filling at Cytiva, Ola Tuvesson, Chief Technology Officer at NorthX Biologics & Sofie Östemar, Product Manager, Connected & Continuous at Cytiva

Xentria and Meitheal partner to develop a breakthrough drug for pulmonary sarcoidosis, aiming to improve patient outcomes.

We take a look at the work of Sir Gregory Winter, and how it has changed the landscape of therapeutic antibody production.

A new collaboration from the Medicines Manufacturing Innovation Centre is looking to change the face of oligonucleotide development.

In honour of this week marking Type 2 Diabetes Prevention Week, we take a look at the intricate link between the disease and proteins.

The Sustainable Healthcare Coalition (SHC) emphasises the importance of collaboration with industry to address climate change in healthcare.

Sony and Astellas join forces to develop an ADC platform that leverages Sony's Kiravia Backbone for enhanced drug delivery and stability.

A program to reduce the waste of medicines and waste from medicines, centred around six pillars for sustainable pharma.

John Lopez of Novartis discusses the more sustainable possibilities refractive index monitoring offers in SPPS and SPOS.

Key opinion leaders discuss techniques for peptide characterisation and the challenges posed by increasing regulatory requirements.

Novo Nordisk has implemented recombinant peptide production techniques with chemical and enzymatic transformations to reduce its carbon footprint in insulin production, as explained by Thomas Høeg-Jensen, Scientific Director at Novo Nordisk.

April 25th marks World Malaria Day, an opportunity to raise awareness about the disease’s impact and efforts to control and prevent it.